AstraZeneca considers moving stock market listing from London to the United States.

From Yahoo Finance: 2025-07-01 10:58:00

AstraZeneca is considering moving its stock market listing from London to the United States, potentially impacting the UK stock market and aligning with President Trump’s investment goals. CEO Pascal Soriot has shown a preference for the move, citing the UK’s business climate. The company has been strengthening ties with the U.S., its largest market. AstraZeneca’s U.S. plans include a $3.5 billion investment in domestic manufacturing by 2026. Soriot may face opposition from board members and the UK government. London-listed shares in AstraZeneca last traded up 2.8%.



Read more at Yahoo Finance: AstraZeneca considers moving listing to US, the Times reports